American Century Companies’s ALX Oncology ALXO Stock Holding History

American Century Companies’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.4K	Buy	+21,434	New	+$38.4K	﹤0.01%	2872
2024 Q3	–	Sell	-23,685	Closed	-$143K	–	2883
2024 Q2	$143K	Sell	23,685 -5,978	-20%	-$73.5K	﹤0.01%	2781
2024 Q1	$331K	Buy	29,663 +8,467	+40%	+$119K	﹤0.01%	2605
2023 Q4	$316K	Buy	21,196 +10,939	+107%	+$104K	﹤0.01%	2542
2023 Q3	$49.2K	Buy	+10,257	New	+$55.7K	﹤0.01%	2807

Other funds holding ALXO

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

American Century Companies's ALXO Position: Q2 2026 in Review

American Century Companies opened a new position in ALX Oncology (ALXO) in Q2 2026: 21,434 shares worth $44.4K. The stake represents ﹤0.01% of the portfolio and ranks #2872 among its holdings. This is a return to the name: American Century Companies previously reported a position in ALXO as recently as Q2 2024.

American Century Companies first reported a position in ALXO in Q3 2023 and has held it in 5 quarters since. The position peaked at $331K in Q1 2024. 93 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

American Century Companies held 21,434 shares of ALX Oncology worth $44.4K as of Q2 2026.
ALX Oncology was a new American Century Companies position in Q2 2026.
ALX Oncology made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2872 holding.
American Century Companies first reported a position in ALX Oncology in Q3 2023 and has held it in 5 quarters since.
American Century Companies's ALX Oncology position peaked at $331K in Q1 2024.
93 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.